Member Info for Lolades78

I think we'll see a blue day. Far too much excitement about this undervalued share. And a lot of big anouncements by Argo this week.

Ok, thank you for your responses. I hope things work out. It just seems fustrating to see others pull ahead. What would happen if no news this week? A drop?

What could be the reason of the delay with Phase 3? They've stretched the word 'imminent' beyond it's most wild interpretation now. The GSK therapeutic will release it's data in early January. If we haven't started and their data is good then surely it's going to do a number on us. I read this today about it "VIR-7832 has been engineered with the potential to enhance lung bioavailability, have an extended half-life, and function as a therapeutic and/or prophylactic T cell vaccine.".

I'm sorry for the rant but I just feel like we are being overlooked and others are pulling ahead. Why do they have big government preorders and not us? I'm sorry I just want some news soon.

That RNS has nothing to do with Phase 3 start. RM said multiple times that it would start in Q4 2020. And we still haven't heard anything.

What is happening?

It makes me sad to see the language being used here.

These two were on twitter and in the news.

Glasko Kline Smith VIR-7831 "The broad anti-coronavirus activity of VIR-7831 allows it to help those patients and add to our preparedness for related coronaviruses that could emerge in the future.” Works against all coronavirus and targets lungs as well as the goverments have already preordered them for stockpilling for future coronavirus'. It's a single infusion. Part of activ-3.

"VIR-7831 (also known as GSK4182136) is a fully human anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus-2) investigational monoclonal antibody that was selected based on its potential to neutralize the virus, kill infected cells, provide a high barrier to resistance and achieve high concentrations in the lungs (one of the major sites of infection)"

w w w.gsk.com/en-gb/media/press-releases/vir-biotechnology-and-gsk-announce-start-of-nih-sponsored-activ-3-trial-evaluating-vir-7831-in-hospitalised-adults-with-covid-19/

and

AstraZeneca therapeutic
"Researchers believe that AZD7442 could provide immediate and long-term protection to individuals recently exposed to the SARS-CoV-2, to prevent them from developing Covid-19."

«Drug would offer immediate and long-term protection to patients when it would be too late to offer a vaccine»

"Another study, PROVENT, is analysing the use of AZD7442 in individuals who may not respond to vaccination (people with a compromised immune system) or those who are at high risk of Covid-19 infection, owing to factors like age and existing conditions."

It's a single outpatient jab that gives 12 month protection.

w w w.dailymail.co.uk/news/article-9088541/The-drug-gives-instant-immunity-coronavirus-UK-trials-new-antibody-therapy

They are also being developed for non-hospital settings just like SNG001.

Google: GlaxoSmithKline/Vir Biotechnology’s and AstraZeneca’ mAbs eyed in early COVID-19

w w w.pharmaceutical-technology.com/comment/glaxosmithkline-vir-biotechnologys-and-astrazeneca-mabs-eyed-in-early-covid-19/
I don't see how my concerns are a deramp. Both of these have started phase 3 and are being fast tracked as well as big government preorders. I've just asked for peoples opinions as I am worried about my investment. What happens if we don't get an RNS tomorrow while these continue on? And my original question remains: why don't we have any preorders if they do? All my funds are in this because I was so sure it would be out there now but it is not.

Kind regards

Lola

Hello,

I’ve been invested since August on the spike so sitting with a loss atm but managed to average down a bit. There has been so much good research by members here so I’ve stuck with the company but now there are a few things that are really worrying me. Firstly, I believe we were promised the phase 3 trial start in Q4 several times by RM. That has been missed which I was sad to see. Secondly I see there are now several new therapeutics already in phase 3 with FDA fast track and large government preorders. The two therapeutics I’ve read about on twitter and in the news are by Astrazeneca and Glasko Kline Smith. The one by GKS targets the lungs and both are a single treatment as well as being effective against the new variants. I see that they are also talking about goverment stockpilling. Are we falling behind? And why don’t we have preorders? And now they will be vaccinating 2 million people a week in the UK as well as the trials by AZ and GKS, surely that will slow the SNG trial? Please don’t take this the wrong way but I’m really worried about my return as I was hoping thing would be a lot further along by now after listening to RM. I thought it would be best to send this message now rather than during trading hours.

Kind regards

Lola